Drug Shortage Report for TEVA-TERAZOSIN

Last updated on 2020-02-13 History
Report ID 1643
Drug Identification Number 02230807
Brand name TEVA-TERAZOSIN
Common or Proper name TERAZOSIN
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) TERAZOSIN
Strength(s) 5MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100
ATC code G04CA
ATC description DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2014-03-07
Estimated end date 2022-12-01
Actual end date
Shortage status Actual shortage
Updated date 2020-02-13
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2020-02-13 French Compare
v3 2020-02-13 English Compare
v2 2017-03-13 French Compare
v1 2017-03-13 English Compare